Back to search
FDAFDA · Food and drugs·Recall number D-0144-2017

AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01); Individual Blister (NDC: 68084-022-11), Rx Only, Manufactured by: Actavis Elizabeth, LLC, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217

Published November 30, 2016 · Recall initiated: October 13, 2016

Summary

FDA records drug Class III recall D-0144-2017, published November 30, 2016 and initiated October 13, 2016. Recalling firm: Amerisource Health Services; Status: Terminated; Reported quantity: 5283 cartons (100 capsules per carton = 528,300 capsules); Lot: Lot #155404 ; Exp 01/18 Lot #161139,163060,164054, 164809; Exp 03/18. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Foreign Tablets/Capsules

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amerisource Health Services
Distributor
US
Lot
Lot #155404 ; Exp 01/18 Lot #161139,163060,164054, 164809; Exp 03/18
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was AHP NIFEdipine Capsules, 10mg USP, 100 count carton (NDC: 68084-022-01); Individual Blister (NDC: 68084-022-11), Rx Only, Manufactured by: Actavis Elizabeth, LLC, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217 recalled?

Yes. FDA published recall D-0144-2017 on November 30, 2016. Reported hazard: Presence of Foreign Tablets/Capsules

What should I do if I have this product?

Voluntary: Firm initiated · Letter